Ultragenyx Pharmaceutical Inc. buy Cantor Fitzgerald
Start price
25.09.23
/
50%
€34.40
Target price
25.09.24
€107.74
Performance (%)
11.63%
Price
20.05.24
€38.40
Summary
This prediction is currently active. The prediction currently has a performance of 11.63%. This prediction currently runs until 25.09.24. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Ultragenyx Pharmaceutical Inc. | 1.053% | 1.053% |
iShares Core DAX® | 0.051% | 5.593% |
iShares Nasdaq 100 | 1.808% | 7.445% |
iShares Nikkei 225® | 2.181% | 2.815% |
iShares S&P 500 | 1.040% | 4.975% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $114.00 price target on the stock.
Ratings data for RARE provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€39.80
03.05.24
03.05.24
€99.30
03.05.25
03.05.25
-3.52%
20.05.24
20.05.24
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€46.40
05.04.24
05.04.24
€98.89
05.04.25
05.04.25
-17.24%
20.05.24
20.05.24
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€49.60
27.02.24
27.02.24
€98.68
27.02.25
27.02.25
-22.58%
20.05.24
20.05.24
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€44.60
15.02.24
15.02.24
€105.84
15.02.25
15.02.25
-13.90%
20.05.24
20.05.24
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€40.20
19.01.24
19.01.24
€104.83
19.01.25
19.01.25
-4.48%
20.05.24
20.05.24